CMG PharmaceuticalCMG제약
058820 · KOSDAQ · ₩058820 · CMG제약
₩4,520▼ ₩460 (9.24%)End-of-day · Oct 28, 2026 · End-of-day prices.
Filings
- Trading halt주권매매거래정지해제 (액면병합 주권 변경상장)Oct 26, 2026Open on DART
Predicted impact: Low
Trading resumes after par value consolidation; routine technical relisting, not a new halt.
- 5%+ holding report주식등의대량보유상황보고서(약식)Oct 14, 2026Open on DART
Predicted impact: Low· Actual: −6.6% vs sector, volume 0.0× normal (5 trading days)
- Early Redemption of Convertible Bonds (Including Overseas Convertible Bonds) Prior to Maturity (8th Series)전환사채(해외전환사채포함)발행후만기전사채취득 (제8회차)Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −6.9% vs sector, volume 0.0× normal (5 trading days)
Early redemption of convertible bonds; size not disclosed and small for the company.
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −6.9% vs sector, volume 0.0× normal (5 trading days)
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −6.9% vs sector, volume 0.0× normal (5 trading days)
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 12, 2026Open on DART
Predicted impact: Low· Actual: −6.9% vs sector, volume 0.0× normal (5 trading days)
- Trading halt주권매매거래정지 (주식의 병합, 분할 등 전자등록 변경, 말소)Sep 28, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과Sep 2, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Aug 13, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Aug 13, 2026Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(약식)Aug 7, 2026Open on DART
- Other Market Notice (Designation Concern Issue: Under Management) (Share Price Below ₩1,000)기타시장안내(관리종목지정우려종목) (주가 1,000원 미달)Aug 5, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Jul 22, 2026Open on DART
- Shareholders' meeting called주주총회소집결의 (임시주주총회)Jul 22, 2026Open on DART
- Share Consolidation Decision주식병합결정Jul 22, 2026Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Jul 13, 2026Open on DART
- Securities Issuance Results (Voluntary Disclosure)증권발행결과(자율공시)Jul 7, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jul 7, 2026Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Jun 30, 2026Open on DART
- Sales or supply contract terminated단일판매ㆍ공급계약해지Jun 19, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Apr 13, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Audit report submitted감사보고서제출Mar 19, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 11, 2026Open on DART
- [Corrected] New Facility Investment, etc.[기재정정]신규시설투자등Dec 29, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 8, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 13, 2025Open on DART
- Adjustment of Conversion Price전환가액의조정Sep 11, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 13, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Jun 25, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Jun 9, 2025Open on DART
- Quarterly report (Mar 2025)분기보고서 (2025.03)May 14, 2025Open on DART
- Change of Department Affiliation소속부변경Apr 30, 2025Open on DART
- Exercise of Conversion Rights전환청구권행사Apr 18, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Apr 18, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항 (메조피(Mezofy) 미국 식품의약국(FDA) 품목허가 획득)Apr 16, 2025Open on DART
- [Corrected] New Facility Investment, etc.[기재정정]신규시설투자등Apr 15, 2025Open on DART
- Annual general meeting results정기주주총회결과Mar 28, 2025Open on DART
- Annual report (Dec 2024)사업보고서 (2024.12)Mar 20, 2025Open on DART
- Audit report submitted감사보고서제출Mar 19, 2025Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2025Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: CMG Pharmaceutical / CMG제약 / 058820 / KRX:058820
Source: KRX statistical information